Today: 28 June 2026
Browse Category

NASDAQ:ADPT 19 August 2025 - 6 February 2026

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

Adaptive Biotechnologies shares climbed 6.5% to $17.15 by midday Wednesday, outpacing broader market gains. Biotech ETFs rose about 2.5%. A Form 4 showed Chief People Officer Francis Lo sold 3,125 shares on Jan. 2 under a prearranged 10b5-1 plan, after exercising options. The company is set to present at the J.P. Morgan Healthcare Conference on Jan. 12.
7 January 2026
··
Pfizer Stock After Hours (PFE) on Dec. 15, 2025: What Moved Shares Today—and What to Watch Before Tuesday’s Open

Pfizer Stock After Hours (PFE) on Dec. 15, 2025: What Moved Shares Today—and What to Watch Before Tuesday’s Open

Pfizer shares closed Monday at $26.43, up 2.24%, then slipped to $26.34 after hours. Investors are awaiting Tuesday’s analyst call, where management is set to outline 2026 guidance. The company announced a new autoimmune research deal with Adaptive Biotechnologies, worth up to $890 million in milestones. Trading volume was about 60 million shares, below average.
16 December 2025
···
Biggest Stock Losers Today (December 5, 2025): Parsons, Adaptive Biotechnologies, SentinelOne, SoFi and More Slide Despite Calm Markets

Biggest Stock Losers Today (December 5, 2025): Parsons, Adaptive Biotechnologies, SentinelOne, SoFi and More Slide Despite Calm Markets

The S&P 500 closed at 6,870.40, up 0.19% Friday, while Bitcoin fell 3% to just under $89,300. Parsons plunged 21% after losing a key FAA contract; other steep U.S. decliners included Adaptive Biotechnologies, SentinelOne, and several Brazilian financials. Brazil’s Bovespa index dropped 4% after Jair Bolsonaro endorsed his son for president, sending the real down 3%.
6 December 2025
··········
Biotech Breakthroughs, Pharma Power Moves & Health Shocks: News Roundup (Aug 18–19, 2025)

Biotech Breakthroughs, Pharma Power Moves & Health Shocks: News Roundup (Aug 18–19, 2025)

Genentech is ending its $2 billion cell therapy partnership with Adaptive Biotechnologies, citing cost-cutting but no safety issues. Kriya Therapeutics raised $313 million in Series D funding, one of the year’s largest biotech rounds. The FDA delayed Neurizon’s ALS drug trial review until October due to staffing shortages. Stealth BioTherapeutics has resubmitted its elamipretide application for Barth syndrome after two FDA rejections.
19 August 2025
····

Stock Market Today

  • Aristocrat Leisure Unveils A$1.12 Billion Buy-Back Balance Ahead of July Update
    June 28, 2026, 11:49 AM EDT. Aristocrat Leisure Ltd (ASX:ALL) has repurchased 24.56 million shares, spending A$1.38 billion of its A$2.5 billion buyback program, leaving around A$1.12 billion available. The stock closed at A$58.69 on June 26, up 8.2% for the week, outperforming the S&P/ASX 200 which fell 0.7%. Aristocrat's investor briefing and interim dividend payout of 50 cents per share are scheduled for July 1. With shares currently trading about 20% below their 52-week high of A$73.29, the remaining buyback funds could repurchase roughly 19.1 million shares, supporting the stock amid mixed market sentiment. Analyst consensus suggests modest upside with a 12-month average price target of A$63.34, highlighting cautious optimism ahead of forthcoming updates.

Latest articles

Ripple MiCA Approval Moves RLUSD, XRP (CRYPTO:XRP) Not Focus, in Europe Payments Push

Ripple MiCA Approval Moves RLUSD, XRP (CRYPTO:XRP) Not Focus, in Europe Payments Push

28 June 2026
Ripple’s preliminary Luxembourg crypto license could open regulated EU payments, but XRP traded near $1.05—still 71% below its 2025 high—as investors await proof that RLUSD stablecoin flows drive real demand on the XRP Ledger, not just Ripple’s private platform; RLUSD supply fell 9% in 30 days while XRPL stablecoin value rose 20%.
Plug Power (NASDAQ:PLUG) stock heads into June 30 cash deadline after shares fall five days

Plug Power (NASDAQ:PLUG) stock heads into June 30 cash deadline after shares fall five days

28 June 2026
Plug Power (PLUG) fell 1.17% to $2.54 Friday, capping a five-day, 10.9% slide as volume jumped above average, with investors eyeing a June 30 deadline to close a $132.5M–$142M asset sale to Stream Data Centers—a key liquidity event equal to up to 64% of unrestricted cash and nearly all Q1 operating cash use—amid a shortened trading week before the July 3 market holiday.
Alphabet (NASDAQ:GOOGL) faces Gemini shortage as Chrome training draws crowds

Alphabet (NASDAQ:GOOGL) faces Gemini shortage as Chrome training draws crowds

28 June 2026
Chrome’s 70.25% global browser share cements its role as Alphabet’s key gateway for AI features and ad revenue, with Q1 Search & other ads delivering $60.4 billion—about 55% of total revenue—while Google faces supply limits for Gemini AI and ongoing antitrust risks; shares last quoted at $337.39, down 2.0%.
Go toTop